FDA Approves Merck ’s Pifeltro (doravirine) for the Treatment of HIV-1 in Appropriate Patients

KENILWORTH, N.J.--(BUSINESS WIRE) August 30, 2018 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Pifeltro (doravirine, 100 mg), a new...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news